Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis treatment may affect body hair growth, with a complex relationship between skin and hair growth mechanisms.

Benign skin tumors need accurate diagnosis to ensure proper treatment.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

New treatments targeting specific genes show promise for treating keratin disorders.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Mutant mice help researchers understand hair growth and related genetic factors.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

TPA is about 50 times more effective at promoting tumors than MZ.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Skin problems can be caused or worsened by physical forces and pressure on the skin.

Notch-related genes play a key role in the development and cycling of hair follicles.

Applying a specific inhibitor lightens skin and hair color.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

The document concludes that both internal stem cell factors and external influences like the environment and hormones affect hair loss and aging, with potential treatments focusing on these areas.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Skin and hair can regenerate after injury due to changes in gene activity, with potential links to how cancer spreads. Future research should focus on how new hair follicles form and the processes that trigger their creation.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

The study concluded that PKP1 is essential for skin integrity and hair growth, and its dysfunction causes the symptoms of ectodermal dysplasia/skin fragility syndrome.

Urokinase, a type of protein, helps skin cells multiply faster, especially in newborn mice.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.